If You Have a Zonulin Test Result, Why 107 ng/mL vs 57.0 ng/mL Matters
A zonulin test measures a protein signal linked to tight junction activity in the gut lining, but the assays behind it remain research-grade rather than diagnostic. Blood and stool versions reflect different biological pools, so they cannot be compared directly, and no result should be read alone. An elevated figure warrants a repeat test through the same lab and a conversation with a clinician, not an immediate verdict on your gut health.
TL;DR:
- Blood and stool zonulin tests measure different pools, and their results are not directly comparable, making interpretation and tracking challenging.
- Commercial assays often cross-react with other proteins, leading to high variability and unreliable readings that are not definitive indicators of gut leaky barrier.
- Elevated zonulin levels frequently correlate with metabolic syndrome and obesity markers, rather than specific gut symptoms, and should be contextualized with other inflammation markers.
- Repeat testing using the same lab and sample type, along with corroborating markers like calprotectin or a permeability test, improves clinical usefulness.
- Current research supports zonulin’s role in metabolic health more than in diagnosing gut permeability issues, making it a piece of a larger health puzzle rather than a standalone diagnosis.
Table of Contents
- What zonulin is and how it relates to intestinal permeability
- How is zonulin measured: serum versus stool tests?
- Why do zonulin test results vary so much between labs?
- What does a high or low zonulin result actually tell you?
- Which conditions actually show a link to zonulin levels?
- What raises zonulin levels, and can you influence it?
- What should you do after an abnormal zonulin result?
- Why the zonulin conversation needs more scepticism, not less
- Get personalised support interpreting your results
- Sources
What zonulin is and how it relates to intestinal permeability
Zonulin was identified in 2000 by Alessio Fasano’s research team, which found a protein that loosens the tight junctions holding gut lining cells together. Think of those junctions as the mortar between bricks in a wall. Zonulin acts on the mortar, not the bricks, briefly widening the gaps between cells so larger molecules can pass through where they normally couldn’t.
That widening isn’t always a problem. The gut wall needs some regulated permeability to sample antigens for immune surveillance and to absorb certain nutrients efficiently. Zonulin appears to be one of the switches controlling how open or closed those gaps stay, and the process is meant to be transient, opening briefly in response to specific triggers before junctions tighten back up.
The trouble starts when that opening becomes chronic rather than transient, and here is where the science gets murkier than most wellness content admits. “Leaky gut” has become a catch-all term in popular health writing, often used to explain everything from bloating to skin conditions to fatigue. The physiological reality is narrower: zonulin is one candidate marker of one mechanism among several that regulate gut barrier function, and elevated zonulin does not automatically confirm a state of pathological permeability, let alone identify what caused it.
Barrier biology involves far more than a single protein. Mucus layer thickness, the composition of the microbiome, other junction proteins such as occludin and claudins, and local immune activity all contribute to how selective the gut wall is at any given moment. Zonulin gets attention because it was one of the first mechanisms well characterised in the literature, not necessarily because it is the dominant one.
This matters for anyone staring at a lab report. A zonulin number tells you about the activity of one regulatory pathway, measured imperfectly, at a single point in time. It doesn’t tell you whether your gut is “leaky” in the sense that phrase is used online, and it doesn’t diagnose a specific disease. It’s a signal worth having in context, not a verdict on its own.
How is zonulin measured: serum versus stool tests?
Laboratories measure zonulin in two main sample types, and they are not testing the same thing. Serum tests draw from a blood sample and estimate the circulating pool of zonulin in the bloodstream at that moment. Stool tests measure zonulin shed into the gut lumen and captured in faecal matter, reflecting local gut activity rather than what has entered systemic circulation.
That distinction sounds technical, but it has a direct practical consequence: a high serum reading and a high stool reading are not interchangeable evidence of the same problem. One reflects what has crossed into the blood; the other reflects what is happening inside the gut itself before absorption. Studies calibrate thresholds separately for each sample type, and mixing the two when tracking a value over time produces numbers that cannot be sensibly compared.
Most commercial and research assays use an ELISA (enzyme-linked immunosorbent assay) format. In simple terms, the sample is exposed to antibodies designed to bind zonulin, and a colour-change reaction indicates how much of the target protein is present. It’s a well-established laboratory technique, used across immunology and endocrinology, and it works well when the antibodies are genuinely selective for the molecule they claim to detect.
That selectivity is exactly where zonulin testing runs into trouble. The protein biologically identified as zonulin is pre-haptoglobin 2, but several commercial kits were built around antibodies that were never confirmed to bind that specific molecule with the precision the marketing implies. This antibody problem is explored in detail in the next section, but it explains why lab-to-lab variability in zonulin testing tends to run higher than for well-established markers such as CRP or ferritin.
The practical takeaway for anyone repeating a test is straightforward: use the same laboratory and, ideally, the same sample type every time. Switching labs midway through monitoring introduces a variable that has nothing to do with your gut and everything to do with which antibody kit happened to be on the bench that week. If your clinician wants to track a trend over months, consistency in methodology matters more than the absolute number on any single report.
Faecal calprotectin testing follows a more standardised path with tighter inter-lab agreement, which is one reason clinicians often lean on it as a companion marker rather than relying on zonulin in isolation. FoodConnection’s guide to calprotectin interpretation covers how that marker behaves differently and where the two tests complement each other.
Why do zonulin test results vary so much between labs?
The core criticism of zonulin testing isn’t about the biology, it’s about the antibodies. A widely cited investigation found that commercial ELISA kits marketed as zonulin tests frequently cross-react with other circulating proteins, including properdin, complement C3, and haptoglobin, none of which is pre-haptoglobin 2, the molecule zonulin actually refers to. Some kits, when tested against a recombinant sample of the genuine protein, failed to reliably detect it at all.
That finding matters enormously for anyone trying to read a report at face value. If a test kit is picking up signal from complement proteins involved in immune activation rather than the tight junction regulator it claims to measure, an elevated number could reflect systemic inflammation from something entirely unrelated to gut permeability, a recent infection, or even normal biological variation in complement activity.
There is also no agreed reference range across the field the way there is for, say, fasting glucose or thyroid-stimulating hormone. Different studies have used different cut-offs depending on the population studied, the assay manufacturer, and the statistical method chosen to define “elevated.” A cohort study investigating faecal zonulin in MASLD (metabolic dysfunction-associated steatotic liver disease) patients illustrates this well: the manufacturer’s suggested threshold was 107 ng/mL, but when researchers recalibrated the cut-off specifically for their own cohort, the statistically optimal threshold dropped to 57.0 ng/mL.
An AUC of 0.68 sits in the range statisticians describe as poor to fair discrimination, better than a coin toss but nowhere near the 0.90+ range expected of a strong diagnostic test. That single figure captures the whole problem with zonulin testing better than any paragraph of caveats could: the biology is plausible, the signal is real, but the measurement tool isn’t precise enough yet to carry the diagnostic weight some marketing puts on it.
What does a high or low zonulin result actually tell you?
A number on its own tells you almost nothing useful. Context is what turns a zonulin figure into information you can act on, and several common factors can push levels up or down independent of anything happening at the gut wall.
- Body composition: studies have linked higher circulating zonulin to larger waist circumference and features of metabolic syndrome, not necessarily to gut symptoms.
- Recent infection: an active viral or bacterial illness can transiently raise inflammatory and permeability-related markers.
- NSAID use: anti-inflammatory painkillers taken in the days before testing are a known confounder for gut permeability markers generally.
- Systemic inflammation: any inflammatory process elsewhere in the body can shift the reading, particularly given the cross-reactivity concerns already covered.
- Laboratory and assay choice: the same blood sample sent to two different labs can return meaningfully different numbers.
The metabolic link deserves particular attention because it flips the usual assumption on its head. A cohort of 363 adults found serum zonulin correlated with waist circumference and diastolic blood pressure, but the relationship to gut symptoms was far less clear. That means a high reading in someone with metabolic risk factors might be telling you more about their metabolic health than their digestive system, an important distinction if the test was ordered specifically to investigate bloating or irregular bowel habits.
Statistic callout: The gap between the manufacturer’s default threshold (107 ng/mL) and a cohort-calibrated threshold (57.0 ng/mL) in the MASLD study isn’t a rounding error; it’s roughly a halving of the cut-off once researchers adjusted for their specific population. That single comparison should make anyone treating a lab report’s reference range as fixed and universal think twice.
Clinicians who take zonulin seriously as a signal, rather than dismissing it outright, generally don’t act on it in isolation. They corroborate it. Faecal calprotectin, a well-validated marker of intestinal inflammation, is a common companion test, alongside CRP for systemic inflammation. Where a more direct measure of permeability is genuinely needed, the lactulose–mannitol test remains the more established gold standard, tracking how two differently sized sugar molecules cross the gut wall and comparing their recovery in urine.
That combination approach reflects a broader principle in functional medicine: any single biomarker is a data point, not a diagnosis. A high zonulin reading alongside normal calprotectin and CRP tells a very different story from a high zonulin reading alongside elevated inflammatory markers and active GI symptoms. Reading the numbers together, rather than fixating on one, is where the real clinical value sits.
Which conditions actually show a link to zonulin levels?
The evidence for zonulin’s clinical relevance is strongest, though still far from conclusive, in metabolic and liver disease. The MASLD cohort discussed earlier found faecal zonulin elevated in a meaningful subset of patients with moderate to severe steatosis, and the association held even after cohort-specific recalibration, suggesting a genuine, if modest, link between gut barrier signalling and fatty liver progression.
Obesity and broader metabolic syndrome show a similarly consistent pattern across multiple studies, with elevated zonulin tracking alongside waist circumference, blood pressure, and dysglycaemia. Whether zonulin is a cause, a consequence, or simply a fellow traveller of metabolic dysfunction remains genuinely unresolved. The correlational studies available cannot separate those possibilities.
Coeliac disease has the longest research history with zonulin, given that Fasano’s original work connected zonulin release to gliadin exposure in genetically predisposed individuals. That mechanistic story is well established at a laboratory level, but zonulin testing has not replaced coeliac serology (tissue transglutaminase antibodies) or biopsy as the diagnostic standard, precisely because assay reliability hasn’t reached that bar.
Inflammatory bowel conditions show associations in some studies, though the picture is less consistent than for metabolic disease, and results often depend heavily on which assay kit a given study used, which loops back to the cross-reactivity problem.
The kinds of studies producing this evidence matter for how much weight to give the findings. Most of what exists are cohort studies (following a group over time or comparing groups at one point) or case-control studies (comparing people with a condition to those without). Systematic reviews of this literature consistently flag assay inconsistency as the reason stronger conclusions aren’t yet possible.
Practically, this puts zonulin testing in a specific lane. It has genuine value as a research tool and as one input among several in complex cases where a clinician is building a broader picture of metabolic or gut health. It has not earned a place as a standalone, routine diagnostic test the way blood glucose or thyroid panels have. Anyone ordering a zonulin test should go in expecting a piece of a puzzle, not a headline finding.
What raises zonulin levels, and can you influence it?
Several dietary and lifestyle factors show up repeatedly in the literature as plausible drivers of zonulin release, though the strength of evidence varies by trigger.
- Gliadin exposure: in genetically predisposed individuals, particularly those with coeliac disease, gluten-derived gliadin is the best-characterised trigger for zonulin release.
- High-fat and highly processed diets: several studies associate these dietary patterns with elevated permeability markers generally, zonulin included.
- Acute infection: gut or systemic infections can transiently spike zonulin and related inflammatory signals.
- Psychological stress: the gut-brain axis research links acute and chronic stress to changes in gut barrier function.
- NSAID use: regular use of anti-inflammatory painkillers is a recognised confounder for permeability testing broadly.
None of these triggers demands a dramatic response on the strength of one lab value. The interventions that tend to help, reducing highly processed food intake, managing weight where relevant, and addressing underlying systemic inflammation, are sensible for general gut and metabolic health whether or not a zonulin number happens to be elevated on a given day. That’s a useful reframe: you’re not chasing a number, you’re supporting a system, and the number is one imperfect window into how that system is functioning.
Pro Tip: If you’re waiting on clinical follow-up after an elevated result, avoid NSAIDs and unusually restrictive diets for at least a few days before any repeat test, and book the retest with the same laboratory. Changing too many variables at once makes it impossible to tell whether a shift in the number reflects biology or just testing noise.
What should you do after an abnormal zonulin result?
An unexpected number on a lab report is unsettling, but the path forward is fairly structured once you know what to ask for.
- Repeat the test through the same laboratory. Given how much variability exists between assay kits, a single reading is weak evidence of anything; a consistent result over two tests using the same method carries more weight.
- Request corroborating markers. Faecal calprotectin and CRP give a broader picture of gut and systemic inflammation, helping distinguish a metabolic signal from an active inflammatory one.
- Consider a lactulose–mannitol permeability test if precision matters. This remains the more established direct measure of gut wall permeability where clinical decisions genuinely hinge on that specific question.
- Watch for red-flag symptoms that need urgent referral regardless of zonulin status. Unexplained weight loss, GI bleeding, severe persistent diarrhoea, or systemic symptoms such as fever alongside gut complaints warrant a gastroenterology referral without waiting on any zonulin recheck.
At FoodConnection, functional lab results are never read in a vacuum. Zonulin, when it forms part of a client’s testing panel, gets interpreted alongside dietary history, symptom patterns, and other markers such as calprotectin or a GI-MAP stool panel, because a number without context tends to generate anxiety rather than clarity.
That approach reflects how functional lab testing actually works best in practice: not as a single test chasing a single answer, but as one layer in a fuller picture built alongside a client’s history, symptoms, and lifestyle.
Why the zonulin conversation needs more scepticism, not less
The conventional wellness framing treats zonulin as settled science: measure it, and you know your gut is “leaky.” The peer-reviewed literature tells a more cautious story, and that gap is exactly where misinformation thrives.
What the evidence actually supports is narrower and, frankly, more interesting: zonulin is a real biological mechanism worth studying, tangled up with metabolic health as much as gut health, and currently measured by tools that aren’t precise enough to carry the diagnostic certainty often sold alongside the test. The AUC of 0.68 in the MASLD cohort is the number I’d want every reader to sit with. That’s a coin flip with a slight edge, not a verdict.
Where I’d push back hardest is on the instinct to either dismiss the test entirely or treat one number as gospel. Both miss the point. The reader’s priority should be corroboration: repeat testing, companion markers, and clinical context, before drawing any conclusion about their gut health. That’s slower and less satisfying than a single number promising an answer, but it’s the only version of this that holds up.
— Irina
Get personalised support interpreting your results
Nutrition consulting services exist for situations when you have a lab report, a genuine question about what it means for your body, and no interest in generic advice pulled from a wellness blog. Where most people are left staring at a number with a manufacturer’s reference range and no clinical context, Personalised nutrition programmes can be built around your actual results, history and symptoms.
If zonulin, calprotectin, or a broader gut panel has come back with anything unclear, functional lab testing and interpretation through Foodconnection gives you a structured way to make sense of it alongside ongoing dietary guidance rather than a one-off consultation and a photocopied information sheet. For those dealing with digestive symptoms, metabolic concerns, or weight management alongside an unclear test result, the personalised nutrition programmes combine lab-based insight with continuous support over weeks, not a single appointment. Book a consultation through Foodconnection to get your results read properly, in context, by someone who will actually explain what they mean for you.
This article is general information, not a substitute for advice from a qualified doctor. Consult a qualified healthcare professional about your own circumstances before acting on anything here.